Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls

CNS oncology

Volumn 3, Issue 4, 2014, Pages 287-298

  Dahlrot, Rikke H ^a   Sørensen, Mia D ^a   Rosager, Ann M ari ^a   Hellwege, Sofie ^a   Bangsø, Julie A ^a   Rosenberg, Tine ^a   Petterson, Stine A ^a   Klitkou, Jacob ^a   Fosmark, Sigurd ^a   Hansen, Steinbjørn ^a   Kristensen, Bjarne W ^a  

^a Department of Oncology ^*  (Denmark)

Author keywords

biomarker; classifier; digital pathology; glioblastoma; glioma; quantification; sampling; slide scanning

Indexed keywords

BIOLOGICAL MARKER; DNA GLYCOSYLTRANSFERASE; DNA-3-METHYLADENINE GLYCOSIDASE II; GLUCOSE TRANSPORTER 3; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN;

BIOLOGICAL MODEL; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMAN; MALE; METABOLISM; PATHOLOGY;

BIOLOGICAL MARKERS; BRAIN NEOPLASMS; DNA GLYCOSYLASES; FEMALE; GLIOMA; GLUCOSE TRANSPORTER TYPE 3; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KI-67 ANTIGEN; MALE; MODELS, BIOLOGICAL;

EID: 84937718771     PISSN: None     EISSN: 20450915     Source Type: Journal    
DOI: 10.2217/cns.14.30     Document Type: Article

References (0)